Abstract
dc:description.abstractNormal haemopoiesis derives from a bone marrow pool of pluripotent stem cells capable of self renewal and multilineage differentiation. Further developments in autografting and gene therapy will rely on a clearer definition and understanding of these primitive cells and an ability to manipulate them effectively. Phenotypic and functional differences between bone marrow and peripheral blood stem cells have been identified and exploited. Techniques for the mobilisation and harvesting of stem cells are established in clinical practice but consensus is lacking on the optimum approach for different diseases. In malignancy, there is great interest in removing contaminating tumour cells from harvests in the hope of reducing relapse rates. Stem cell selection using the CD34 antigen has been commonly used for such purging strategies. The concentration of stem cells produced by CD34 selection provides an ideal product for further manipulation by cell expansion and /or genetic modification. These techniques should facilitate the future engineering of more specific therapeutic cell products.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 1998
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Johnson, Roderick
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/28306